Genome editing trial suggests cure for blood diseases

Recent tests have established a potential cure for sickle cell disease and beta thalassaemia by using genome editing on bone marrow stem cells

The impact of Covid-19 on rare disease communities

Guest author Dr Christine Patch explains the challenges in supporting patients with rare disease during the pandemic, as well as the opportunities that may arise

Genomic trigger found for inflammation

Could we ‘turn off’ our body’s unwanted immune responses? New research has found a genetic switch in our non-coding DNA that could help treat complex allergic disease